Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 117 pages | ID: G90B3DBEE04GEN
GlobalInfoResearch

Abstracts

Nonalcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic. The major feature in NASH is fat deposition in the liver, along with inflammation and damage to the liver. Most patients with NASH are not aware that they are suffering from a liver problem. However, NASH can become severe and can lead to cirrhosis, in which the liver is permanently damaged.

SCOPE OF THE REPORT:

This market is boosted by the growing prevalence of diabetes and obesity, and high investments for research and development, which leads to rising demand for NASH and others nonalcoholic fatty liver diseases (NAFLD) therapies in the market. As per the regional analysis, the well-established healthcare infrastructure with the high adoption rate of new technologies and increasing research activities, makes North America dominate this market.
The global Non-Alcoholic Steatohepatitis (NASH) Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-Alcoholic Steatohepatitis (NASH) Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Non-Alcoholic Steatohepatitis (NASH) Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-Alcoholic Steatohepatitis (NASH) Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers

• AstraZeneca
• Conatus Pharmaceuticals
• Enzo Biochem
• Galmed Pharmaceuticals
• Genfit
• Gilead
• Horizon Pharma
• Immuron
• Intercept Pharmaceuticals
• Novo Nordisk

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Vitamin E & Pioglitazone
• Obeticholic Acid (OCA)
• Elafibranor
• Selonsertib & Cenicriviroc

Market Segment by Applications, can be divided into

• Hospital Pharmacy
• Online Provider
• Retail Pharmacy

Contents

1 NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Non-Alcoholic Steatohepatitis (NASH) Drugs
1.2 Classification of Non-Alcoholic Steatohepatitis (NASH) Drugs by Types
  1.2.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Comparison by Types (2017-2023)
  1.2.2 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Types in 2017
  1.2.3 Vitamin E & Pioglitazone
  1.2.4 Obeticholic Acid (OCA)
  1.2.5 Elafibranor
  1.2.6 Selonsertib & Cenicriviroc
1.3 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market by Application
  1.3.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacy
  1.3.3 Online Provider
  1.3.4 Retail Pharmacy
1.4 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market by Regions
  1.4.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Non-Alcoholic Steatohepatitis (NASH) Drugs Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-Alcoholic Steatohepatitis (NASH) Drugs Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Alcoholic Steatohepatitis (NASH) Drugs Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Non-Alcoholic Steatohepatitis (NASH) Drugs Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Alcoholic Steatohepatitis (NASH) Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Non-Alcoholic Steatohepatitis (NASH) Drugs (2013-2023)

2 MANUFACTURERS PROFILES

2.1 AstraZeneca
  2.1.1 Business Overview
  2.1.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 AstraZeneca Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Conatus Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Conatus Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Enzo Biochem
  2.3.1 Business Overview
  2.3.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Enzo Biochem Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Galmed Pharmaceuticals
  2.4.1 Business Overview
  2.4.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genfit
  2.5.1 Business Overview
  2.5.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Genfit Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Gilead
  2.6.1 Business Overview
  2.6.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Gilead Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Horizon Pharma
  2.7.1 Business Overview
  2.7.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Horizon Pharma Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Immuron
  2.8.1 Business Overview
  2.8.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Immuron Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Intercept Pharmaceuticals
  2.9.1 Business Overview
  2.9.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novo Nordisk
  2.10.1 Business Overview
  2.10.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Novo Nordisk Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS MARKET COMPETITION, BY PLAYERS

3.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Non-Alcoholic Steatohepatitis (NASH) Drugs Players Market Share
  3.2.2 Top 10 Non-Alcoholic Steatohepatitis (NASH) Drugs Players Market Share
3.3 Market Competition Trend

4 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS MARKET SIZE BY REGIONS

4.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Market Share by Regions
4.2 North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS REVENUE BY COUNTRIES

5.1 North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Countries (2013-2018)
5.2 USA Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)

6 EUROPE NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS REVENUE BY COUNTRIES

6.1 Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Countries (2013-2018)
6.2 Germany Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
6.4 France Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS REVENUE BY COUNTRIES

7.1 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Countries (2013-2018)
7.2 China Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
7.5 India Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS REVENUE BY COUNTRIES

8.1 South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Countries (2013-2018)
8.2 Brazil Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS BY COUNTRIES

9.1 Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)

10 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS MARKET SEGMENT BY TYPE

10.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Forecast by Type (2018-2023)
10.3 Vitamin E & Pioglitazone Revenue Growth Rate (2013-2023)
10.4 Obeticholic Acid (OCA) Revenue Growth Rate (2013-2023)
10.5 Elafibranor Revenue Growth Rate (2013-2023)
10.6 Selonsertib & Cenicriviroc Revenue Growth Rate (2013-2023)

11 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Application (2013-2018)
11.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacy Revenue Growth (2013-2018)
11.4 Online Provider Revenue Growth (2013-2018)
11.5 Retail Pharmacy Revenue Growth (2013-2018)

12 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRUGS MARKET SIZE FORECAST (2018-2023)

12.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Forecast (2018-2023)
12.2 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Forecast by Regions (2018-2023)
12.3 North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)
12.6 South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Non-Alcoholic Steatohepatitis (NASH) Drugs Picture
Table Product Specifications of Non-Alcoholic Steatohepatitis (NASH) Drugs
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Types in 2017
Figure Vitamin E & Pioglitazone Picture
Figure Obeticholic Acid (OCA) Picture
Figure Elafibranor Picture
Figure Selonsertib & Cenicriviroc Picture
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) by Application (2013-2023)
Figure Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Applications in 2017
Figure Hospital Pharmacy Picture
Figure Online Provider Picture
Figure Retail Pharmacy Picture
Table Global Market Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table AstraZeneca Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Conatus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Conatus Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table Conatus Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Enzo Biochem Basic Information, Manufacturing Base and Competitors
Table Enzo Biochem Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table Enzo Biochem Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Galmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Genfit Basic Information, Manufacturing Base and Competitors
Table Genfit Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table Genfit Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table Gilead Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table Horizon Pharma Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table Horizon Pharma Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Immuron Basic Information, Manufacturing Base and Competitors
Table Immuron Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table Immuron Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Non-Alcoholic Steatohepatitis (NASH) Drugs Type and Applications
Table Novo Nordisk Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Share by Players (2013-2018)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Share by Players in 2016
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share in 2017
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Regions in 2017
Figure North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Table North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Countries (2013-2018)
Table North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries in 2017
Figure USA Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Table Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries in 2017
Figure Germany Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure UK Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure France Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries in 2017
Figure China Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure India Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Table South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Countries (2013-2018)
Table South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries in 2017
Figure Brazil Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue and Growth Rate (2013-2018)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Share by Type (2013-2018)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Share by Type (2013-2018)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Share by Type in 2017
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Forecast by Type (2018-2023)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share Forecast by Type (2018-2023)
Figure Global Vitamin E & Pioglitazone Revenue Growth Rate (2013-2018)
Figure Global Obeticholic Acid (OCA) Revenue Growth Rate (2013-2018)
Figure Global Elafibranor Revenue Growth Rate (2013-2018)
Figure Global Selonsertib & Cenicriviroc Revenue Growth Rate (2013-2018)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Application (2013-2018)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Share by Application (2013-2018)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Share by Application (2013-2018)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Share by Application in 2017
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Forecast by Application (2018-2023)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Online Provider Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)
Figure Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)
Figure South America Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Forecast (2018-2023)